Financhill
Buy
85

DXT.TO Quote, Financials, Valuation and Earnings

Last price:
$11.84
Seasonality move :
0.88%
Day range:
$11.87 - $12.15
52-week range:
$6.88 - $12.21
Dividend yield:
3.03%
P/E ratio:
18.95x
P/S ratio:
0.74x
P/B ratio:
2.62x
Volume:
19.4K
Avg. volume:
47.8K
1-year change:
61.89%
Market cap:
$745.6M
Revenue:
$1B
EPS (TTM):
$0.63

DXT.TO Analysts' Consensus Rating

The 5 analysts providing 12-month price projections for Dexterra Group, Inc. shares anticipate an average target of $13.32, ranging from a low estimate of $12.00 to a high estimate of $15.50. This average target implies a growth of 11.2% compared to the current stock price of $11.98.

Consensus Price Target

$13.32

Highest Price Target

$15.50

Lowest Price Target

$12.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 4 3 3

Hold 0 2 2

Sell 0 0 0
Consensus Buy Buy Buy

DXT.TO Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is down 4.73% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is up 7.57% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is down 7.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock